(1) Background: We explored, for the first time, the contribution of angiogenic T cells (TAng) in
interstitial lung disease associated to
autoimmune disease (AD-ILD+) as potential
biomarkers of the disease, evaluating their role in the underlying vasculopathy and lung
fibrosis. Additionally, the relationship of TAng with clinical manifestations and cellular and molecular endothelial dysfunction-related
biomarkers was assessed. (2) Methods: We included 57 AD-ILD+ patients (21 with
rheumatoid arthritis (RA)-ILD+, 21 with
systemic sclerosis (SSc)-ILD+ and 15 with other AD-ILD+) and three comparative groups: 45 AD-ILD- patients (25 RA-ILD- and 20 SSc-ILD-); 21
idiopathic pulmonary fibrosis (IPF) patients; 21 healthy controls (HC). TAng were considered as CD3+CD184+CD31+ by flow cytometry. (3) Results: A similar TAng frequency was found between AD-ILD+ and IPF, being in both cases lower than that observed in AD-ILD- and HC. A lower TAng frequency was associated with negative Scl-70 status and lower FEV1/FVC ratio in SSc-ILD+, as well as with men in RA-ILD+ and non-specific
interstitial pneumonia radiological pattern in other AD-ILD+. No relationship between TAng and endothelial progenitor cells, endothelial cells and
vascular endothelial growth factor gene expression and
protein levels was disclosed. (4) Conclusions: Our findings suggest TAng as potential
biomarkers for the early diagnosis of ILD in AD.